文献速递血栓与止血

血浆中血小板来源微囊泡水平与未来静脉血栓栓塞风险相关

Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism.
PubMed 文献 · J Thromb Haemost · 2022-01-19

基于Tromsø研究的巢式病例对照研究纳入314例静脉血栓栓塞(VTE)病例与705名年龄性别匹配对照,检测基线血浆血小板来源微囊泡比例(PDMVs%)。PDMVs%最高四分位组VTE的OR为1.78(95%CI:1.21-2.64),诱发性VTE的OR为1.99(95%CI:1.24-3.26),提示血小板活化可能参与VTE发病。

要点

  • 基线PDMVs%最高四分位组未来VTE风险升高,OR 1.78(95%CI:1.21-2.64)。
  • 诱发性VTE的OR为1.99(95%CI:1.24-3.26),高于总体VTE关联。
  • 采血与事件间隔越短,VTE的OR越高。

核心结论

  • 高比例PDMVs与未来新发VTE风险相关,提示血小板活化可能参与VTE发病。

研究设计与样本

  • 基于Tromsø研究的人群巢式病例对照研究,纳入314例VTE病例和705名年龄、性别匹配对照。
  • 基线(VTE发生前)血浆分离微囊泡,染色血小板标志物后流式细胞术分析。
  • PDMVs%定义为PDMVs数量除以微囊泡总数,按PDMVs%四分位估计VTE风险的OR及95%CI。

主要发现

  • PDMVs%最高四分位组VTE的OR为1.78(95%CI:1.21-2.64),参照为最低四分位组。
  • PDMVs%最高四分位组诱发性VTE的OR为1.99(95%CI:1.24-3.26),参照为最低四分位组。
  • 对年龄、性别、体重指数、C反应蛋白、血小板计数和癌症进行多变量校正后,关联受到中等程度影响。
  • 采血与事件间隔时间越短,VTE的OR越高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microvesicles (MVs) are small double-membrane encapsulated particles shed from cells. Case-control studies have reported elevated plasma levels of platelet-derived MVs (PDMVs) in patients with venous thromboembolism (VTE). However, it is not known whether high PDMV levels is a risk factor or a consequence of the acute VTE event. OBJECTIVES: To investigate the association between PDMVs in plasma and risk of future incident VTE. METHODS: We performed a population-based nested case-control study with 314 VTE cases and 705 age- and sex-matched controls (from The Tromsø Study) to investigate the association between the proportion of PDMVs (PDMVs%) in plasma and risk of future incident VTE. MVs isolated from plasma sampled at baseline (i.e., before VTE) were stained for platelet markers and analyzed by flow cytometry. PDMVs% were defined as the number of PDMVs divided by the total number of MVs. Odds ratios (ORs) with 95% confidence intervals (CI) for VTE risk were estimated across quartiles of PDMVs%. RESULTS: Subjects with PDMVs% in the highest quartile had an OR for VTE of 1.78 (95% CI: 1.21-2.64) and 1.99 (95% CI: 1.24-3.26) for provoked VTE, compared to those in the lowest quartile. The association was moderately affected by multivariable adjustment for age, sex, body mass index, C-reactive protein, platelet count, and cancer. The OR for VTE was higher when the time between blood sampling and event was shorter. CONCLUSIONS: Our results show that high proportions of PDMVs are associated with future risk of incident VTE and imply a role of platelet activation in the pathogenesis of VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Snir O, Wilsgård L, Latysheva N, et al. Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism. J Thromb Haemost. 2022. PMID: 35000275. doi:10.1111/jth.15638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。